Shifted phase of EEG cross-frequency coupling in individuals with Phelan-McDermid syndrome.


Journal

Molecular autism
ISSN: 2040-2392
Titre abrégé: Mol Autism
Pays: England
ID NLM: 101534222

Informations de publication

Date de publication:
28 04 2021
Historique:
received: 22 06 2020
accepted: 28 12 2020
entrez: 29 4 2021
pubmed: 30 4 2021
medline: 5 3 2022
Statut: epublish

Résumé

Phelan-McDermid Syndrome (PMS) is a rare condition caused by deletion or mutation of the SHANK3 gene. Individuals with PMS frequently present with intellectual disability, autism spectrum disorder, and other neurodevelopmental challenges. Electroencephalography (EEG) can provide a window into network-level function in PMS. Here, we analyze EEG data collected across multiple sites in individuals with PMS (n = 26) and typically developing individuals (n = 15). We quantify oscillatory power, alpha-gamma phase-amplitude coupling strength, and phase bias, a measure of the phase of cross frequency coupling thought to reflect the balance of feedforward (bottom-up) and feedback (top-down) activity. We find individuals with PMS display increased alpha-gamma phase bias (U = 3.841, p < 0.0005), predominantly over posterior electrodes. Most individuals with PMS demonstrate positive overall phase bias while most typically developing individuals demonstrate negative overall phase bias. Among individuals with PMS, strength of alpha-gamma phase-amplitude coupling was associated with Sameness, Ritualistic, and Compulsive behaviors as measured by the Repetitive Behavior Scales-Revised (Beta = 0.545, p = 0.011). Increased phase bias suggests potential circuit-level mechanisms underlying phenotype in PMS, offering opportunities for back-translation of findings into animal models and targeting in clinical trials.

Sections du résumé

BACKGROUND
Phelan-McDermid Syndrome (PMS) is a rare condition caused by deletion or mutation of the SHANK3 gene. Individuals with PMS frequently present with intellectual disability, autism spectrum disorder, and other neurodevelopmental challenges. Electroencephalography (EEG) can provide a window into network-level function in PMS.
METHODS
Here, we analyze EEG data collected across multiple sites in individuals with PMS (n = 26) and typically developing individuals (n = 15). We quantify oscillatory power, alpha-gamma phase-amplitude coupling strength, and phase bias, a measure of the phase of cross frequency coupling thought to reflect the balance of feedforward (bottom-up) and feedback (top-down) activity.
RESULTS
We find individuals with PMS display increased alpha-gamma phase bias (U = 3.841, p < 0.0005), predominantly over posterior electrodes. Most individuals with PMS demonstrate positive overall phase bias while most typically developing individuals demonstrate negative overall phase bias. Among individuals with PMS, strength of alpha-gamma phase-amplitude coupling was associated with Sameness, Ritualistic, and Compulsive behaviors as measured by the Repetitive Behavior Scales-Revised (Beta = 0.545, p = 0.011).
CONCLUSIONS
Increased phase bias suggests potential circuit-level mechanisms underlying phenotype in PMS, offering opportunities for back-translation of findings into animal models and targeting in clinical trials.

Identifiants

pubmed: 33910615
doi: 10.1186/s13229-020-00411-9
pii: 10.1186/s13229-020-00411-9
pmc: PMC8082621
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

29

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH113948
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090255
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS092090
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIC MH002961
Pays : United States

Références

Brain Connect. 2015 Mar;5(2):80-90
pubmed: 25109843
Front Hum Neurosci. 2010 Oct 19;4:191
pubmed: 21060716
Cell Tissue Res. 2006 Nov;326(2):409-22
pubmed: 16865346
Pediatr Res. 2009 Jun;65(6):599-606
pubmed: 19454962
J Am Acad Dermatol. 2007 Oct;57(4):610-5
pubmed: 17574298
J Neurodev Disord. 2017 Mar 14;9:11
pubmed: 28316753
Neuron. 2002 Jan 17;33(2):163-75
pubmed: 11804565
J Neurosci. 2012 May 9;32(19):6525-41
pubmed: 22573675
Neurobiol Dis. 2016 Apr;88:125-38
pubmed: 26792400
Mol Autism. 2017 Jun 7;8:22
pubmed: 28596820
Trends Cogn Sci. 2012 Oct;16(10):504-10
pubmed: 22959875
Eur J Paediatr Neurol. 2014 Nov;18(6):677-84
pubmed: 24912731
Nat Neurosci. 2020 Apr;23(4):520-532
pubmed: 32123378
Orphanet J Rare Dis. 2015 Aug 27;10:105
pubmed: 26306707
Am J Hum Genet. 1994 Mar;54(3):464-72
pubmed: 7906921
Nat Neurosci. 2016 May;19(5):716-724
pubmed: 26928064
Front Mol Neurosci. 2019 Jun 18;12:155
pubmed: 31275112
Front Neurosci. 2018 Aug 07;12:513
pubmed: 30131667
Am J Med Genet. 2001 Jun 15;101(2):91-9
pubmed: 11391650
Epilepsia. 2016 Oct;57(10):1651-1659
pubmed: 27554343
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9158-65
pubmed: 26170299
Cereb Cortex. 2016 Jan;26(1):268-278
pubmed: 25316340
Front Cell Neurosci. 2019 Oct 10;13:458
pubmed: 31649512
Front Neurosci. 2018 Feb 27;12:97
pubmed: 29535597
Nat Rev Neurosci. 2017 Nov;18(11):671-684
pubmed: 28951611
Front Neurosci. 2015 Dec 22;9:454
pubmed: 26733778
Mol Autism. 2014 Apr 25;5:30
pubmed: 25071925
J Cogn Dev. 2018;19(2):182-200
pubmed: 30333714
Nature. 2011 Apr 28;472(7344):437-42
pubmed: 21423165
Autism Res. 2019 Aug;12(8):1211-1224
pubmed: 31119899
PLoS Comput Biol. 2017 Dec 11;13(12):e1005893
pubmed: 29227989
J Neurodev Disord. 2013 Sep 16;5(1):24
pubmed: 24040879
IEEE Trans Biomed Eng. 2014 May;61(5):1555-64
pubmed: 24759284
Epilepsy Behav. 2018 Mar;80:312-320
pubmed: 29402632
Trends Neurosci. 2015 Nov;38(11):725-740
pubmed: 26549886
Eur J Neurosci. 2016 Aug;44(4):2147-61
pubmed: 27320148
Curr Biol. 2013 Jun 17;23(12):1101-6
pubmed: 23746635
Elife. 2016 Sep 26;5:
pubmed: 27669144
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
J Autism Dev Disord. 2000 Jun;30(3):237-43
pubmed: 11055459
eNeuro. 2017 Jan 16;3(6):
pubmed: 28101528
Neuron. 2020 Jun 3;106(5):769-777.e4
pubmed: 32199104
Science. 2006 Sep 15;313(5793):1626-8
pubmed: 16973878
Trends Cogn Sci. 2010 Nov;14(11):506-15
pubmed: 20932795
Brain Connect. 2019 Jun;9(5):425-436
pubmed: 30900464
PLoS Comput Biol. 2017 Dec 11;13(12):e1005879
pubmed: 29227992
Brain Connect. 2019 Apr;9(3):263-272
pubmed: 30588822
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3107-12
pubmed: 23319621
J Neurosci. 2011 Mar 30;31(13):4935-43
pubmed: 21451032
J Neurophysiol. 2010 Aug;104(2):1195-210
pubmed: 20463205
Mol Autism. 2017 Jun 15;8:26
pubmed: 28638591
Mol Autism. 2013 Jun 11;4(1):18
pubmed: 23758760
Nat Commun. 2016 May 10;7:11459
pubmed: 27161151

Auteurs

Michael G Mariscal (MG)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.

Elizabeth Berry-Kravis (E)

Department of Pediatrics, Rush University Medical Center, Chicago, IL, USA.
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Department of Biochemistry, Rush University Medical Center, Chicago, IL, USA.

Joseph D Buxbaum (JD)

Seaver Autism Center, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA.
Department of Neuroscience, Mount Sinai School of Medicine, New York, NY, USA.

Lauren E Ethridge (LE)

Department of Pediatrics, University of Oklahoma Health Science Center, Oklahoma City, OK, USA.

Rajna Filip-Dhima (R)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.

Jennifer H Foss-Feig (JH)

Seaver Autism Center, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Alexander Kolevzon (A)

Seaver Autism Center, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Meera E Modi (ME)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.

Matthew W Mosconi (MW)

Clinical Child Psychology Program, Schiefelbusch Institute for Life Span Studies, University of Kansas, Lawrence, KS, USA.

Charles A Nelson (CA)

Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Craig M Powell (CM)

Department of Neurobiology, UAB School of Medicine, Birmingham, AL, USA.

Paige M Siper (PM)

Seaver Autism Center, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Latha Soorya (L)

Department of Psychiatry, Rush University Medical Center, Chicago, IL, USA.

Andrew Thaliath (A)

Department of Pediatrics, Rush University Medical Center, Chicago, IL, USA.

Audrey Thurm (A)

Intramural Research Program, National Institute of Mental Health, Bethesda, USA.

Bo Zhang (B)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.

Mustafa Sahin (M)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.

April R Levin (AR)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA. April.Levin@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH